Skip to main content

Acutus Medical, Inc. (AFIB)

NASDAQ: AFIB · IEX Real-Time Price · USD
9.91 -0.37 (-3.60%)
Sep 21, 2021 3:48 PM EDT - Market open
Market Cap280.54M
Revenue (ttm)14.05M
Net Income (ttm)-118.60M
Shares Out27.94M
EPS (ttm)-4.73
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume220,978
Open10.28
Previous Close10.28
Day's Range9.46 - 10.51
52-Week Range9.46 - 34.35
Betan/a
AnalystsBuy
Price Target20.67 (+108.6%)
Est. Earnings DateNov 11, 2021

About AFIB

Acutus Medical, Inc., an arrhythmia management company, designs, manufactures, and markets a range of tools for catheter-based ablation procedures to treat various arrhythmias in the United States and internationally. Its product portfolio includes novel access sheaths, transseptal crossing tools, diagnostic and mapping catheters, conventional and contact force ablation catheters, and mapping and imaging consoles and accessories, as well as supporting algorithms and software programs. Acutus Medical, Inc. was incorporated in 2011 and is based i...

IndustryMedical Devices
IPO DateAug 6, 2020
Employees291
Stock ExchangeNASDAQ
Ticker SymbolAFIB
Full Company Profile

Financial Performance

In 2020, Acutus Medical's revenue was $8.46 million, an increase of 198.45% compared to the previous year's $2.84 million. Losses were -$101.98 million, 5.09% more than in 2019.

Financial Statements

Analyst Forecast

According to 5 analysts, the average rating for Acutus Medical stock is "Buy." The 12-month stock price forecast is 20.67, which is an increase of 108.58% from the latest price.

Price Target
$20.67
(108.58% upside)
Analyst Consensus: Buy

News

Acutus Medical, Inc. (AFIB) Reports Q2 Loss, Tops Revenue Estimates

Acutus Medical, Inc. (AFIB) delivered earnings and revenue surprises of 11.00% and 1.27%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?

1 month ago - Zacks Investment Research

Acutus Medical Appoints Niamh Pellegrini to Board of Directors

CARLSBAD, Calif., Aug. 12, 2021 (GLOBE NEWSWIRE) -- Acutus Medical (“Acutus”) (Nasdaq: AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and treated,...

1 month ago - GlobeNewsWire

Acutus Medical Reports Second Quarter 2021 Financial Results

CARLSBAD, Calif., Aug. 12, 2021 (GLOBE NEWSWIRE) -- Acutus Medical, Inc. (“Acutus” or the “Company”) (Nasdaq: AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias are...

1 month ago - GlobeNewsWire

Acutus Medical to Participate at the 6th Annual Needham Virtual Med Tech & Diagnostics 1x1 Conference

CARLSBAD, Calif., Aug. 03, 2021 (GLOBE NEWSWIRE) -- Acutus Medical, Inc. (“Acutus”) (Nasdaq: AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and tr...

1 month ago - GlobeNewsWire

Acutus Medical to Announce Second Quarter 2021 Financial Results

CARLSBAD, Calif., July 29, 2021 (GLOBE NEWSWIRE) -- Acutus Medical, Inc. (“Acutus”) (Nasdaq: AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and tr...

1 month ago - GlobeNewsWire

AliveCor and Acutus Medical Partner to Evaluate Management and Treatment of Cardiac Arrhythmias

MOUNTAIN VIEW, Calif., July 27, 2021 /PRNewswire/ -- AliveCor, Inc. ("AliveCor"), a leading innovator in FDA-cleared personal electrocardiogram (ECG) technology and services, and Acutus Medical ("Acutus...

1 month ago - PRNewsWire

Acutus Medical, Inc. Announces Full Exercise of Underwriter's Option to Purchase Additional Shares

CARLSBAD, Calif., July 26, 2021 (GLOBE NEWSWIRE) -- Acutus Medical, Inc. (Nasdaq: AFIB) (“Acutus”) today announced that the underwriter of its previously announced public offering, which closed on July ...

1 month ago - GlobeNewsWire

Acutus Medical, Inc. Announces Pricing of Public Offering of Common Stock

CARLSBAD, Calif., July 14, 2021 (GLOBE NEWSWIRE) -- Acutus Medical, Inc. (Nasdaq: AFIB) (“Acutus”) today announced the pricing of its underwritten public offering of 5,500,000 shares of its common stock...

2 months ago - GlobeNewsWire

Acutus Medical, Inc. Announces Proposed Public Offering of Common Stock

CARLSBAD, Calif., July 12, 2021 (GLOBE NEWSWIRE) -- Acutus Medical, Inc. (“Acutus” or the “Company”) (Nasdaq: AFIB) today announced it has commenced an underwritten public offering of 5,500,000 shares o...

2 months ago - GlobeNewsWire

Acutus Medical Reports Preliminary Unaudited Second Quarter 2021 Financial Results

CARLSBAD, Calif., July 12, 2021 (GLOBE NEWSWIRE) -- Acutus Medical, Inc. (“Acutus” or the “Company”) (Nasdaq: AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias are...

2 months ago - GlobeNewsWire

Acutus Medical Receives Green Signal From FDA To Start AcQBlate Atrial Fibrillation Trial

The FDA has signed off Investigational Device Exemption (IDE) AcQBlate AF trial for Acutus Medical Inc's (NASDAQ: AFIB) AcQBlate Force Sensing Ablation Catheter and System. The trial is expected to enro...

3 months ago - Benzinga

Acutus Medical Receives FDA Approval to Initiate US Atrial Fibrillation IDE Trial with the AcQBlate® FORCE Sensing Ab...

CARLSBAD, Calif., May 27, 2021 (GLOBE NEWSWIRE) -- Acutus Medical (Nasdaq: AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and treated, today annou...

3 months ago - GlobeNewsWire

Acutus Medical to Present at the 41st Annual William Blair Growth Stock Conference

CARLSBAD, Calif., May 20, 2021 (GLOBE NEWSWIRE) -- Acutus Medical, Inc. (“Acutus”) (Nasdaq: AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and tre...

4 months ago - GlobeNewsWire

Acutus Medical Reports First Quarter 2021 Financial Results

CARLSBAD, Calif., May 12, 2021 (GLOBE NEWSWIRE) -- Acutus Medical, Inc. (“Acutus” or the “Company”) (Nasdaq: AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias are ...

4 months ago - GlobeNewsWire

Acutus Medical to Announce First Quarter 2021 Financial Results

CARLSBAD, Calif., April 28, 2021 (GLOBE NEWSWIRE) -- Acutus Medical, Inc. (“Acutus”) (Nasdaq: AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and t...

4 months ago - GlobeNewsWire

Acutus Medical to Participate in Upcoming Investor Conferences

CARLSBAD, Calif., April 20, 2021 (GLOBE NEWSWIRE) -- Acutus Medical, Inc. (“Acutus”) (Nasdaq: AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and t...

5 months ago - GlobeNewsWire

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Acutus Medical, Inc. - AFIB

NEW YORK, April 6, 2021 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Acutus Medical, Inc. ("Acutus" or the "Company") (NASDAQ: AFIB). Such investors are advised to con...

5 months ago - PRNewsWire

Acutus Medical Initiates First IDE Therapy Trial with the AcQBlate® FORCE Sensing Ablation System

CARLSBAD, Calif., April 05, 2021 (GLOBE NEWSWIRE) -- Acutus Medical (Nasdaq: AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and treated, today ann...

5 months ago - GlobeNewsWire

Acutus Medical to Present at the 20ᵗʰ Annual Needham Virtual Healthcare Conference

CARLSBAD, Calif., March 30, 2021 (GLOBE NEWSWIRE) -- Acutus Medical, Inc. (“Acutus”) (Nasdaq: AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and t...

5 months ago - GlobeNewsWire

Acutus Medical Reports Fourth Quarter and Full Year 2020 Financial Results

CARLSBAD, Calif., March 18, 2021 (GLOBE NEWSWIRE) -- Acutus Medical, Inc. (“Acutus”) (Nasdaq: AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and t...

6 months ago - GlobeNewsWire

Acutus Medical to Announce Fourth Quarter and Full Year 2020 Financial Results

CARLSBAD, Calif., March 04, 2021 (GLOBE NEWSWIRE) -- Acutus Medical, Inc. (“Acutus”) (Nasdaq: AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and t...

6 months ago - GlobeNewsWire

Acutus Medical Receives Vizient Innovative Technology Contract

Contract Pricing Now Widely Available for the AcQMap® High Resolution 3D Imaging and Mapping System Contract Pricing Now Widely Available for the AcQMap® High Resolution 3D Imaging and Mapping System

6 months ago - GlobeNewsWire

Acutus Medical, Inc. Appoints New Chief Financial Officer and New Board Member

CARLSBAD, Calif., Feb. 09, 2021 (GLOBE NEWSWIRE) -- Acutus Medical (Nasdaq: AFIB) today announced the appointment of David Roman as the company's Chief Financial Officer, effective March 1, 2021. In add...

7 months ago - GlobeNewsWire

Acutus Medical to Present at the BTIG Virtual MedTech, Digital Health, Life Science and Diagnostic Tools Conference

CARLSBAD, Calif., Feb. 04, 2021 (GLOBE NEWSWIRE) -- Acutus Medical, Inc. (“Acutus”) (Nasdaq: AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and tr...

7 months ago - GlobeNewsWire

Acutus Medical Reports Preliminary, Unaudited Fourth Quarter and Full Year 2020 Results

CARLSBAD, Calif., Jan. 13, 2021 (GLOBE NEWSWIRE) -- Acutus Medical, Inc. (“Acutus”) (Nasdaq: AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and tr...

8 months ago - GlobeNewsWire